[Preoperative Induction Therapy for Locally Advanced Thymic Tumors: A Retrospective Analysis Using the ChART...

Area of Science:

• Thoracic Surgery
• Surgical Oncology
• Neoadjuvant Therapy

Background:

• Locally advanced thymic malignancies pose treatment challenges.
• Evaluating the impact of preoperative induction therapy on prognosis is crucial.

Purpose of the Study:

• To assess the role of preoperative induction therapy in improving outcomes for locally advanced thymic malignancies.
• To compare the prognosis of patients receiving induction therapy versus direct surgery.

Main Methods:

• Retrospective analysis of patients from the Chinese Alliance for Research in Thymomas (ChART) database (1994-2012).
• Comparison between induction therapy (IT) group and direct surgery (DS) group.
• Subgroup analysis excluding stage IV patients to focus on stages I-III.

Main Results:

• Only 4% of patients received induction therapy, with a 67.6% R0 resection rate.
• Downstaging occurred in 25% of IT patients; thymomas were more frequently downstaged than thymic carcinomas.
• Downstaged tumors had significantly higher 5-year overall survival (OS) (93.8%) compared to non-downstaged tumors (35.6%).
• In subgroup analysis (stages I-III), 5-year OS was 68.1% for IT vs. 85.2% for DS (P<0.001).
• However, downstaged tumors in the IT group achieved OS (93.8%) similar to the DS group (85.2%).

Conclusions:

• Preoperative induction therapy can lead to tumor downstaging in locally advanced thymic malignancies.
• Tumor downstaging after induction therapy is associated with significantly improved long-term survival.
• While overall survival in the IT group was lower than DS in subgroup analysis, downstaged tumors achieved comparable survival to the DS group.